Africa Large Volume Parenterals Market Size to Reach USD 1,133 million by 2024, At CAGR of 7.9%
September 23, 2022
Africa large volume parenterals (LVP) market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics.
PORTLAND, OREGON, UNITED STATES, September 22, 2022 /EINPresswire.com/ -- Africa large volume parenterals (LVP) market was valued at $662 million in 2017, and is expected to reach $1,133 million by 2024, growing at a CAGR of 7.9% from 2018 to 2024. Parenteral route of drug administration refers to administration of drugs through non-oral routes. Large volume parenterals, also termed as large volume injections, are aqueous solutions usually supplied in volumes of at least 100 ml. They include calcium solutions, sodium chloride, ringer's, sodium bicarbonate and other electrolyte solutions, dextrose (glucose) & other sugar solutions, amino acid, peptide & other protein fraction solutions, solutions containing a combination of the above, sometimes with vitamins added, dextrans, and other plasma expanders.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/4613
Increase in prevalence of chronic diseases, rapid surge in number of surgeries, and rise in risk of malnutrition are the major factors that drive the growth of the Africa large volume parenterals (LVP) market. However, preference for enteral nutrition and high risk of infection/allergic reaction during a parenteral administration restrain the market growth. Conversely, increase in demand for palliative care services in Africa is expected to offer potential growth opportunities for the market in the near future.
On the basis of treatment type, fluid balance injections segment dominated the market in 2017 by garnering nearly two-thirds share, and is expected to maintain its dominance during the analysis period. This is attributed to the fact that fluid balance injections can be used for a broad customer base, including patients who are critically ill, septic, with major cardiac, liver or renal comorbidity, or after a major surgery.
Based on route of administration, the intravenous segment held the major market share of more than four-fifths in 2017, and is expected to dominate the market throughout the analysis period, since it is the fastest way to deliver large volume parenterals, as the drug is easily carried throughout the body with the help of circulation.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/4613
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
• Intramuscular segment is expected to grow with a CAGR of 8.2% from 2018 to 2024.
• By treatment type, the nutritious injections segment is expected to grow at the highest CAGR of 9.1% from 2018 to 2024.
• The 500 ml capacity segment held a major share of more than four-fifths and three-fourths in terms of value and volume, respectively, in 2017, and is expected to maintain this trend throughout the analysis period.
• South Africa held a major share of more than one-fifth in the African market in 2017, and is expected to retain it throughout the analysis period.
• Namibia is expected to register a CAGR of 7.7% from 2018 to 2024.
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
𝐀𝐥𝐬𝐨 𝐑𝐞𝐚𝐝 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐁𝐥𝐨𝐠:
Singapore Artificial Intelligence in Medicine Market -- https://singaporehealthcarenews.blogspot.com/2022/09/singapore-artificial-intelligence-in.html
Singapore Neurological Biomarkers Market -- https://singaporehealthcarenews.blogspot.com/2022/09/singapore-neurological-biomarkers.html
𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.